Safety and preliminary efficacy of argatroban plus dual antiplatelet therapy for acute mild to moderate ischemic stroke with large artery atherosclerosis
Abstract Objective Previous studies suggest the benefit of dual antiplatelet therapy (DAPT) for acute ischemic stroke with large artery atherosclerosis (LAA) etiology, but there is no study about the effect of DAPT plus anticoagulant in this population. Methods A prospective single arm trial was per...
Main Authors: | Xiao‐Qiu Li, Xiao‐Wen Hou, Yu Cui, Xiao‐Fu Tian, Xin‐Hong Wang, Zhong‐He Zhou, Hui‐Sheng Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-07-01
|
Series: | Brain and Behavior |
Subjects: | |
Online Access: | https://doi.org/10.1002/brb3.2664 |
Similar Items
-
Dual vs. mono antiplatelet therapy for acute ischemic stroke or transient ischemic attack with evidence of large artery atherosclerosis
by: Chun-Jen Lin, et al.
Published: (2022-09-01) -
The effect of argatroban on early neurological deterioration and outcomes in minor ischemic stroke: preliminary findings
by: Xuehong Jin, et al.
Published: (2024-03-01) -
Efficacy and safety of Argatroban in patients with acute ischemic stroke: a systematic review and meta-analysis
by: YiRan Cheng, et al.
Published: (2024-02-01) -
Effect of Anticoagulants or Antiplatelets Administration on Mortality Case in COVID-19 Patients with Acute Ischemic Stroke: A Systematic Review and Meta-Analysis
by: Galuh Anis Tasya, et al.
Published: (2022-01-01) -
Antiplatelet therapy strategies for ischemic stroke
by: M. Yu. Maksimova, et al.
Published: (2017-07-01)